HK Stock MarketDetailed Quotes

SKB BIO (06990)

Watchlist
  • 451.000
  • -4.000-0.88%
Noon Break May 8 11:52 CST
105.17BMarket Cap-248.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SKB BIO (06990) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
许可及合作协议收入1.5B72.79%
Drug sales income542.7M26.37%
提供研发服务收入17.18M0.83%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
许可及合作协议收入1.5B72.79%
Drug sales income542.7M26.37%
提供研发服务收入17.18M0.83%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
United States of America.1.31B63.89%
People's Republic of China571.2M27.76%
Switzerland168.69M8.20%
Other countries3.31M0.16%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 -0.30%
Sample Name
Sample Code
 -0.40%
4
SINOPEC CORP
00386
-0.86%
5
PETROCHINA
00857
-1.49%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +63.51%
Sample Name
Sample Code
 +51.73%
Sample Name
Sample Code
 +46.26%
4
Loongson Technology Corporation
688047
+36.26%
5
Business-intelligence Of Oriental Nations Corporation
300166
+31.93%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -